Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.

The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.

A journal is forced to remove a record-breaking number of papers—and all in one go.

Papers from Catherine Verfaillie’s lab have been drawing fire for years.

A study estimates that 0.15 percent of genetics articles are retracted, most commonly for duplication and plagiarism.

The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.

Problems with Brian Wansink’s research articles surfaced in 2017 and have now resulted in 13 retractions total.

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.

The authors of a preprint recommend that journals implement better image screening procedures before publishing articles.